Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Juno Therapeutics, Inc. | 10,552,390 | reported | 15 Mar 2016 | tx 7+10,455,375−11,455,375 |
| Sage Therapeutics, Inc. | 3,968,252 | reported | 23 Jul 2014 | tx 6+4,249,389−13,385,583 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Mar 2016 | OTHER | Juno Therapeutics, Inc. | 1,000,000 | — | |
| 23 Dec 2014 | CONVERSION | Juno Therapeutics, Inc. | 3,747,500 | — | |
| 23 Dec 2014 | CONVERSION | Juno Therapeutics, Inc. | 457,875 | — | |
| 23 Dec 2014 | CONVERSION | Juno Therapeutics, Inc. | 6,250,000 | — | |
| 23 Dec 2014 | CONVERSION | Juno Therapeutics, Inc. | 6,250,000 | — | deriv |
| 23 Dec 2014 | CONVERSION | Juno Therapeutics, Inc. | 3,747,500 | — | deriv |
| 23 Dec 2014 | CONVERSION | Juno Therapeutics, Inc. | 457,875 | — | deriv |
| 23 Jul 2014 | CONVERSION | Sage Therapeutics, Inc. | 885,583 | — | deriv |
| 23 Jul 2014 | CONVERSION | Sage Therapeutics, Inc. | 1,587,301 | — | |
| 23 Jul 2014 | CONVERSION | Sage Therapeutics, Inc. | 2,380,951 | — | |
| 23 Jul 2014 | CONVERSION | Sage Therapeutics, Inc. | 281,137 | — | |
| 23 Jul 2014 | CONVERSION | Sage Therapeutics, Inc. | 5,000,000 | — | deriv |
| 23 Jul 2014 | CONVERSION | Sage Therapeutics, Inc. | 7,500,000 | — | deriv |